193 related articles for article (PubMed ID: 11744100)
21. Activation of the liver X receptor increases neuroactive steroid levels and protects from diabetes-induced peripheral neuropathy.
Cermenati G; Giatti S; Cavaletti G; Bianchi R; Maschi O; Pesaresi M; Abbiati F; Volonterio A; Saez E; Caruso D; Melcangi RC; Mitro N
J Neurosci; 2010 Sep; 30(36):11896-901. PubMed ID: 20826654
[TBL] [Abstract][Full Text] [Related]
22. Progesterone and its metabolites increase myelin basic protein expression in organotypic slice cultures of rat cerebellum.
Ghoumari AM; Ibanez C; El-Etr M; Leclerc P; Eychenne B; O'Malley BW; Baulieu EE; Schumacher M
J Neurochem; 2003 Aug; 86(4):848-59. PubMed ID: 12887683
[TBL] [Abstract][Full Text] [Related]
23. Phenotypic differences between peripheral myelin protein-22 (PMP22) and myelin protein zero (P0) mutations associated with Charcot-Marie-Tooth-related diseases.
Shames I; Fraser A; Colby J; Orfali W; Snipes GJ
J Neuropathol Exp Neurol; 2003 Jul; 62(7):751-64. PubMed ID: 12901701
[TBL] [Abstract][Full Text] [Related]
24. Molecular alterations resulting from frameshift mutations in peripheral myelin protein 22: implications for neuropathy severity.
Johnson JS; Roux KJ; Fletcher BS; Fortun J; Notterpek L
J Neurosci Res; 2005 Dec; 82(6):743-52. PubMed ID: 16273544
[TBL] [Abstract][Full Text] [Related]
25. Neuroactive steroids: A therapeutic approach to maintain peripheral nerve integrity during neurodegenerative events.
Leonelli E; Ballabio M; Consoli A; Roglio I; Magnaghi V; Melcangi RC
J Mol Neurosci; 2006; 28(1):65-76. PubMed ID: 16632876
[TBL] [Abstract][Full Text] [Related]
26. Neuroactive steroids and GABAA receptor plasticity in the brain of the WAG/Rij rat, a model of absence epilepsy.
Pisu MG; Mostallino MC; Dore R; Mura ML; Maciocco E; Russo E; De Sarro G; Serra M
J Neurochem; 2008 Sep; 106(6):2502-14. PubMed ID: 18624910
[TBL] [Abstract][Full Text] [Related]
27. Steroid metabolism and effects in central and peripheral glial cells.
Melcangi RC; Magnaghi V; Martini L
J Neurobiol; 1999 Sep; 40(4):471-83. PubMed ID: 10453050
[TBL] [Abstract][Full Text] [Related]
28. Neuroactive steroid treatment modulates myelin lipid profile in diabetic peripheral neuropathy.
Mitro N; Cermenati G; Brioschi E; Abbiati F; Audano M; Giatti S; Crestani M; De Fabiani E; Azcoitia I; Garcia-Segura LM; Caruso D; Melcangi RC
J Steroid Biochem Mol Biol; 2014 Sep; 143():115-21. PubMed ID: 24607810
[TBL] [Abstract][Full Text] [Related]
29. Comparative analysis of Schwann cell lines as model systems for myelin gene transcription studies.
Hai M; Muja N; DeVries GH; Quarles RH; Patel PI
J Neurosci Res; 2002 Aug; 69(4):497-508. PubMed ID: 12210843
[TBL] [Abstract][Full Text] [Related]
30. Docetaxel-induced peripheral neuropathy: protective effects of dihydroprogesterone and progesterone in an experimental model.
Roglio I; Bianchi R; Camozzi F; Carozzi V; Cervellini I; Crippa D; Lauria G; Cavaletti G; Melcangi RC
J Peripher Nerv Syst; 2009 Mar; 14(1):36-44. PubMed ID: 19335538
[TBL] [Abstract][Full Text] [Related]
31. Progesterone and its derivatives are neuroprotective agents in experimental diabetic neuropathy: a multimodal analysis.
Leonelli E; Bianchi R; Cavaletti G; Caruso D; Crippa D; Garcia-Segura LM; Lauria G; Magnaghi V; Roglio I; Melcangi RC
Neuroscience; 2007 Feb; 144(4):1293-304. PubMed ID: 17187935
[TBL] [Abstract][Full Text] [Related]
32. Progesterone and its derivatives dihydroprogesterone and tetrahydroprogesterone reduce myelin fiber morphological abnormalities and myelin fiber loss in the sciatic nerve of aged rats.
Azcoitia I; Leonelli E; Magnaghi V; Veiga S; Garcia-Segura LM; Melcangi RC
Neurobiol Aging; 2003 Oct; 24(6):853-60. PubMed ID: 12927767
[TBL] [Abstract][Full Text] [Related]
33. Many facets of the peripheral myelin protein PMP22 in myelination and disease.
Naef R; Suter U
Microsc Res Tech; 1998 Jun; 41(5):359-71. PubMed ID: 9672419
[TBL] [Abstract][Full Text] [Related]
34. Pathogenesis of Charcot-Marie-Tooth 1A (CMT1A) neuropathy.
Hanemann CO; Müller HW
Trends Neurosci; 1998 Jul; 21(7):282-6. PubMed ID: 9683317
[TBL] [Abstract][Full Text] [Related]
35. Levels and actions of progesterone and its metabolites in the nervous system during physiological and pathological conditions.
Melcangi RC; Giatti S; Calabrese D; Pesaresi M; Cermenati G; Mitro N; Viviani B; Garcia-Segura LM; Caruso D
Prog Neurobiol; 2014 Feb; 113():56-69. PubMed ID: 23958466
[TBL] [Abstract][Full Text] [Related]
36. Ultrastructural distribution of PMP22 in Charcot-Marie-Tooth disease type 1A.
Haney C; Snipes GJ; Shooter EM; Suter U; Garcia C; Griffin JW; Trapp BD
J Neuropathol Exp Neurol; 1996 Mar; 55(3):290-9. PubMed ID: 8786387
[TBL] [Abstract][Full Text] [Related]
37. SRC-1 is involved in the control of the gene expression of myelin protein Po.
Cavarretta IT; Martini L; Motta M; Smith CL; Melcangi RC
J Mol Neurosci; 2004; 24(2):217-26. PubMed ID: 15456935
[TBL] [Abstract][Full Text] [Related]
38. Distinct elements of the peripheral myelin protein 22 (PMP22) promoter regulate expression in Schwann cells and sensory neurons.
Maier M; Castagner F; Berger P; Suter U
Mol Cell Neurosci; 2003 Nov; 24(3):803-17. PubMed ID: 14664827
[TBL] [Abstract][Full Text] [Related]
39. A dual role for Integrin α6β4 in modulating hereditary neuropathy with liability to pressure palsies.
Poitelon Y; Matafora V; Silvestri N; Zambroni D; McGarry C; Serghany N; Rush T; Vizzuso D; Court FA; Bachi A; Wrabetz L; Feltri ML
J Neurochem; 2018 May; 145(3):245-257. PubMed ID: 29315582
[TBL] [Abstract][Full Text] [Related]
40. Charcot-Marie-Tooth disease and related inherited neuropathies.
Murakami T; Garcia CA; Reiter LT; Lupski JR
Medicine (Baltimore); 1996 Sep; 75(5):233-50. PubMed ID: 8862346
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
